Staar Surgical Co (STU:SR3) PE Ratio: 351.61 (As of Aug. 14, 2026) — 120% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SR3 Staar Surgical Co STU:SR3
85 GF Score
Price €21.80
GF Value €28.83
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co PE Ratio?

Staar Surgical Co STU:SR3 -1.80% 85 PE Ratio is 351.61 as of Aug. 14, 2026, which is 120% above its 10-year median of 160.04. GuruFocus rates STU:SR3 with a GF Score™ of 85/100 and a GF Value™ of €28.83 (Modestly Undervalued). The stock has 5 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-14), Staar Surgical Co's share price is €21.80. Staar Surgical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €0.06. Therefore, Staar Surgical Co's PE Ratio for today is 351.61.

Warning Sign:

Staar Surgical Co stock PE Ratio (=361.71) is close to 5-year high of 397.

During the past 13 years, Staar Surgical Co's highest PE Ratio was 1832.35. The lowest was 55.02. And the median was 160.04.

Staar Surgical Co's EPS (Diluted) for the three months ended in Jun. 2026 was €0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €0.06.

As of today (2026-08-14), Staar Surgical Co's share price is €21.80. Staar Surgical Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was €0.46. Therefore, Staar Surgical Co's PE Ratio without NRI ratio for today is 47.29.

During the past 13 years, Staar Surgical Co's highest PE Ratio without NRI was 1153.70. The lowest was 41.03. And the median was 117.25.

Staar Surgical Co's EPS without NRI for the three months ended in Jun. 2026 was €0.14. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was €0.46.

During the past 13 years, Staar Surgical Co's highest 3-Year average EPS without NRI Growth Rate was 227.10% per year. The lowest was -34.10% per year. And the median was 14.30% per year.

Staar Surgical Co's EPS (Basic) for the three months ended in Jun. 2026 was €0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was €0.06.

Back to Basics: PE Ratio


Staar Surgical Co  (STU:SR3) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Staar Surgical Co PE Ratio Related Terms


Staar Surgical Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co PE Ratio Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.04 60.68 72.58 At Loss At Loss

Staar Surgical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 409.86

STU:SR3 vs KMTS, AZTA, BLFS: PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's PE Ratio falls into.


STU:SR3
85GF Score
Staar Surgical Co STU:SR3
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Staar Surgical Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=21.80/0.062
=351.61

Staar Surgical Co's Share Price of today is €21.80.
Staar Surgical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.06.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 351.61 mean?
Staar Surgical Co (STU:SR3) has a PE Ratio of 351.61 as of Aug. 14, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Staar Surgical Co and its competitors. This is 120% above median its historical median of 160.04. Over the past decade, Staar Surgical Co's PE Ratio has ranged from 55.02 to 1,832.35.
Is Staar Surgical Co's PE Ratio too high?
Staar Surgical Co's current PE Ratio of 351.61 is 120% above median its 10-year median of 160.04. Over the past 10 years, this metric has ranged from a low of 55.02 to a high of 1,832.35. Overall, Staar Surgical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's PE Ratio compare to KMTS and AZTA?
Staar Surgical Co's PE Ratio of 351.61 can be compared against companies in the Medical Devices & Instruments industry. Historically, Staar Surgical Co's own PE Ratio has ranged from 55.02 to 1,832.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Devices & Instruments company?
A good PE Ratio depends on the Medical Devices & Instruments industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current PE Ratio is 351.61, which is 120% above median its own 10-year median of 160.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STU:SR3) is currently considered Modestly Undervalued. The stock's GF Value™ is €28.83, compared to a current price of €21.80 — trading 24.4% below its estimated fair value. The current PE Ratio is 351.61, which is 120% above median its 10-year median of 160.04. Staar Surgical Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Staar Surgical Co (STU:SR3), the current PE Ratio is 351.61 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (STU:SR3) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of €21.80 is trading 24.4% below its estimated GF Value™ of €28.83. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for STU:SR3:

  • PE Ratio: 351.61 (120% above median its 10-year median of 160.04)
  • GF Value™: €28.83 vs. price of €21.80 (24.4% below fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the STU:SR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staar Surgical Co Business Description

Other Exchanges STAA:USASR3:Germany
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
85GF Score

Get the complete analysis for STU:SR3

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.80
Price
€28.83
GF Value